Regulus Therapeutics Inc (RGLS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Regulus Therapeutics Inc (RGLS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011284
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Regulus Therapeutics Inc (Regulus Therapeutics) is a developer of microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target microRNAs. Its products are used for the therapeutic conditions of hepatitis C infection, cardiovascular disease, cancer, fibrosis, immune inflammatory diseases and metabolic diseases, among others. The company also optimizes anti miRs in several distinct programs, both independently and with its strategic alliance partners. Regulus Therapeutics is headquartered in San Diego, California, the US.

Regulus Therapeutics Inc (RGLS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Regulus Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Regulus Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Regulus Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Regulus Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Regulus Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Regulus Therapeutics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Regulus Therapeutics Enters into Agreement with Biogen Idec for microRNA Biomarkers 10
Regulus Therapeutics Amends Agreement With Biogen Idec 11
Regulus Therapeutics Enters Into An Agreement With Biogen Idec For Biomarkers 12
Equity Offering 13
Regulus Therapeutics Raises USD46 Million in Public Offering of Shares 13
Regulus Therapeutics Inc – Key Competitors 15
Regulus Therapeutics Inc – Key Employees 16
Regulus Therapeutics Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Nov 07, 2017: Regulus Reports Third Quarter 2017 Financial Results and Recent Events 18
Aug 01, 2017: Regulus Reports Second Quarter 2017 Financial Results and Recent Events 19
May 04, 2017: Regulus Reports First Quarter 2017 Financial Results and Corporate Restructuring 20
Mar 02, 2017: Regulus Reports Fourth Quarter 2016 Financial Results and Pipeline Update 21
Nov 01, 2016: Regulus Reports Third Quarter 2016 Financial Results 23
Aug 02, 2016: Regulus Reports Second Quarter 2016 Financial Results 24
May 02, 2016: Regulus Reports First Quarter 2016 Financial Results and Recent Highlights 25
Feb 22, 2016: Regulus Reports Fourth Quarter and Year-End 2015 Financial Results and Recent Highlights 27
Corporate Communications 29
Jun 13, 2017: Regulus Promotes Mark Deeg, M.D. PhD to Chief Medical Officer 29
Jun 01, 2017: Pascale Witz Joins Regulus Board of Directors 30
Oct 05, 2016: Regulus Appoints Timothy M. Wright, M.D. as Chief Research and Development Officer 31
Jun 02, 2016: Regulus Therapeutics: Dr. Hugh Rosen Joins Regulus Board of Directors 32
May 23, 2016: Regulus Appoints Allison Wey as Vice President, Investor Relations & Corporate Communications 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Regulus Therapeutics Inc, Medical Equipment, Key Facts, 2016 2
Regulus Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Regulus Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Regulus Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Regulus Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Regulus Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Regulus Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Regulus Therapeutics Enters into Agreement with Biogen Idec for microRNA Biomarkers 10
Regulus Therapeutics Amends Agreement With Biogen Idec 11
Regulus Therapeutics Enters Into An Agreement With Biogen Idec For Biomarkers 12
Regulus Therapeutics Raises USD46 Million in Public Offering of Shares 13
Regulus Therapeutics Inc, Key Competitors 15
Regulus Therapeutics Inc, Key Employees 16

★海外企業調査レポート[Regulus Therapeutics Inc (RGLS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Development Bank:企業の戦略・SWOT・財務分析
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sosei Heptares (4565):企業の財務・戦略的SWOT分析
    Summary Sosei Heptares(Sosei) formerly known as Sosei Group Corp, is a biopharmaceutical company that develops and commercializes drugs. The company’s pipeline products include NorLevo, NVA237, QVA149 and SO-1105. Its NorLevo product is an oral emergency contraceptive; and SO-1105 is an antifungal a …
  • Enstar Group Ltd.:企業の戦略・SWOT・財務情報
    Enstar Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Enstar Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • 3i Infotech Ltd (3IINFOTECH):企業の財務・戦略的SWOT分析
    3i Infotech Ltd (3IINFOTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Reebok International Ltd.:企業の戦略・SWOT・財務情報
    Reebok International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Reebok International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Imuraya Group Co., Ltd.:企業の戦略・SWOT・財務分析
    Imuraya Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Imuraya Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Spectrum Brands Holdings, Inc.:企業の戦略・SWOT・財務分析
    Spectrum Brands Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Spectrum Brands Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • AutoNation, Inc.:企業の戦略・SWOT・財務情報
    AutoNation, Inc. - Strategy, SWOT and Corporate Finance Report Summary AutoNation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • NuVascular Technologies Inc:企業の製品パイプライン分析2018
    Summary NuVascular Technologies Inc (NuVascular Technologies) is a developer of medical devices for the treatment of patients suffering from end-stage renal diseases. The company offers hemodialysis access grafts, arteriovenous suture, central venous catheter cuffs, drug-eluting vessel wrap, drug-el …
  • Coor Service Management Holding AB:企業の戦略・SWOT・財務情報
    Coor Service Management Holding AB - Strategy, SWOT and Corporate Finance Report Summary Coor Service Management Holding AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • China Digital Culture (Group) Ltd (8175):企業の財務・戦略的SWOT分析
    China Digital Culture (Group) Ltd (8175) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Mobile Telesystems
    Mobile Telesystems - Strategy, SWOT and Corporate Finance Report Summary Mobile Telesystems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CryoTherapeutics Gmbh-医療機器分野:企業M&A・提携分析
    Summary CryoTherapeutics GmbH (CryoTherapeutics) is a medical equipment company that offers systemic drug based approach in combination with a localised device-based therapy. The company’s proprietary cryotherapy system is used for the treatment of coronary artery disease that causes heart attacks. …
  • Deutsche Biotech Innovativ AG (VUA):製薬・医療:M&Aディール及び事業提携情報
    Summary Deutsche Biotech Innovativ AG (DBI), formerly Venetus Beteiligungen AG, is a biotechnology company that develops drug candidates on indications sepsis and cancer. The company’s products comprise Adrecizumab, DB1RA and AB2302. It diagnostic based drug development approach and offers identific …
  • Mitsui E&S Holdings Co., Ltd. (7003):企業の財務・戦略的SWOT分析
    Mitsui E&S Holdings Co., Ltd. (7003) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Euro India Fresh Foods Ltd (EIFFL):企業の財務・戦略的SWOT分析
    Euro India Fresh Foods Ltd (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • OncoSil Medical Ltd (OSL):医療機器:M&Aディール及び事業提携情報
    Summary OncoSil Medical Ltd (OncoSil), formerly Neuro Discovery Ltd, is a medical device company that develops and commercializes products for the treatment of pancreatic and liver cancer. The company’s lead product includes oncosil, a brachytherapy device that emits beta radiation and is implanted …
  • University of Maryland Medical Center Corp:企業の戦略的SWOT分析
    University of Maryland Medical Center Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Algonquin Power & Utilities Corp (AQN):電力:M&Aディール及び事業提携情報
    Summary Algonquin Power & Utilities Corp. (APUC) generates, transmits and distributes energy. It generates electricity through non-regulated renewable and clean energy and thermal generation facilities across North America. The company distributes electricity in California and New Hampshire; natural …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆